TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Bio Forte AS
Closing information (x1000 SEK)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
8,986
|
13,880 | |
| Financial expenses |
6
|
8 | |
| Earnings before taxes |
-199
|
486 | |
| Total assets |
3,506
|
4,587 | |
| Current assets |
3,077
|
4,259 | |
| Current liabilities |
442
|
1,266 | |
| Equity capital |
3,064
|
3,322 | |
| - share capital |
194
|
197 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
87.4%
|
72.4% | |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-2.2%
|
3.5% | |
| Return on assets (ROA) |
-5.5%
|
10.8% | |
| Current ratio |
696.2%
|
336.4% | |
| Return on equity (ROE) |
-6.5%
|
14.6% | |
| Change turnover |
-4,649
|
-51 | |
| Change turnover % |
21%
|
-34%
|
0% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.